Cytokinetics Inc’s filing revealed that its EVP Research & Development Malik Fady Ibraham unloaded Company’s shares for reported $74940.0 on Jul 22 ’25. In the deal valued at $37.47 per share,2,000 shares were sold. As a result of this transaction, Malik Fady Ibraham now holds 140,610 shares worth roughly $5.23 million.
Then, Blum Robert I sold 5,000 shares, generating $190,750 in total proceeds. Upon selling the shares at $38.15, the President & CEO now owns 393,108 shares.
Before that, FADY MALIK bought 14,000 shares. Cytokinetics Inc shares valued at $467,040 were divested by the Officer at a price of $33.36 per share.
Barclays initiated its Cytokinetics Inc [CYTK] rating to an Overweight in a research note published on April 24, 2025; the price target was $55. A number of analysts have revised their coverage, including Citigroup’s analysts, who began to cover the stock in early February with a ‘”a Buy”‘ rating. Stifel began covering CYTK with “Buy” recommendation on January 22, 2025. RBC Capital Mkts started covering the stock on November 08, 2024. It rated CYTK as “an Outperform”.
Price Performance Review of CYTK
On Friday, Cytokinetics Inc [NASDAQ:CYTK] saw its stock fall -0.35% to $37.18. Over the last five days, the stock has lost -0.13%. Cytokinetics Inc shares have fallen nearly -35.20% since the year began. Nevertheless, the stocks have fallen -20.96% over the past one year. While a 52-week high of $61.38 was reached on 01/27/25, a 52-week low of $29.31 was recorded on 05/15/25.
Levels Of Support And Resistance For CYTK Stock
The 24-hour chart illustrates a support level at 36.53, which if violated will result in even more drops to 35.88. On the upside, there is a resistance level at 38.00. A further resistance level may holdings at 38.81.
How much short interest is there in Cytokinetics Inc?
A steep rise in short interest was recorded in Cytokinetics Inc stocks on 2025-07-15, growing by 1.92 million shares to a total of 15.93 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 14.01 million shares. There was a rise of 12.08%, which implies that there is a positive sentiment for the stock.
